Sponsor
Ashley Hinson
Representative · R-IA
Representative · R-IA
The bill creates a new, dedicated revenue stream for expanded and prioritized cancer research (including rare and pediatric cancers) by diverting a portion of tobacco import duties — boosting research capacity and focus but reducing general Treasury receipts, creating funding volatility tied to imports, and adding interagency management complexity.
Patients with cancer and researchers gain new, dedicated federal funding for cancer research (early detection, prevention, and treatments), increasing the pace and scale of research efforts.
Children with pediatric cancers and people with rare cancers receive prioritized attention and funding, improving the chance of new therapies and clinical research for underserved cancer types.
Taxpayers face no immediate new general-tax increase because the bill finances the cancer research fund through a dedicated share of tobacco import duties, creating a predictable, earmarked revenue stream for the program.
Taxpayers and the federal budget will see 10% of tobacco import duties diverted to this fund, reducing Treasury receipts available for other federal priorities or deficit reduction.
Researchers, hospitals, and research programs face funding volatility because tying the program to tobacco import duties makes resources dependent on fluctuating import levels, complicating long-term planning for multi-year studies.
Hospitals, veterans, and program managers will have to coordinate with the Defense Health Agency, adding interagency complexity and the risk that management or priorities shift toward military health needs.
Based on analysis of 2 sections of legislative text.
Establishes a Treasury Cancer Research Trust Fund funded by 10% of gross import duties on tobacco, with HHS using transfers for cancer screening, prevention, treatments, prioritizing rare and pediatric cancers.
Official title: To establish a cancer research trust fund, and for other purposes.
Introduced August 13, 2026 by Ashley Hinson · Last progress August 13, 2026
Creates a Cancer Research Trust Fund in the Treasury funded by annual transfers equal to 10% of gross import duties collected on tobacco and tobacco-substitute articles. The Treasury may transfer money from the Fund to HHS on request so HHS, working with the Defense Health Agency, can pay for research into early screening, prevention, treatments, and innovative therapies, with priority for rare cancers and pediatric cancers. The law sets the funding source and spending direction but leaves program details and annual transfer amounts to collections of the specified import duties and to HHS program decisions made in coordination with the Defense Health Agency.